Cargando…
LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic target
BACKGROUND: Novel biomarkers are required to discern between breast tumors that should be targeted for treatment from those that would never become clinically apparent and/or life threatening for patients. Moreover, therapeutics that specifically target breast cancer (BC) cells with tumor-initiating...
Autores principales: | Hagerling, Catharina, Owyong, Mark, Sitarama, Vaishnavi, Wang, Chih-Yang, Lin, Charlene, van den Bijgaart, Renske J. E., Koopman, Charlotte D., Brenot, Audrey, Nanjaraj, Ankitha, Wärnberg, Fredrik, Jirström, Karin, Klein, Ophir D., Werb, Zena, Plaks, Vicki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285764/ https://www.ncbi.nlm.nih.gov/pubmed/32522170 http://dx.doi.org/10.1186/s12885-020-06986-z |
Ejemplares similares
-
Overcoming Barriers of Age to Enhance Efficacy of Cancer Immunotherapy: The Clout of the Extracellular Matrix
por: Owyong, Mark, et al.
Publicado: (2018) -
MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapy
por: Owyong, Mark, et al.
Publicado: (2019) -
Roles of the immune system in cancer: from tumor initiation to metastatic progression
por: Gonzalez, Hugo, et al.
Publicado: (2018) -
Infiltration of [Formula: see text] T cells, IL-17 [Formula: see text] T cells and FoxP3 [Formula: see text] T cells in human breast cancer
por: Allaoui, Roni, et al.
Publicado: (2018) -
Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study
por: Zhou, Wenjing, et al.
Publicado: (2010)